Showing results (151-160 of 675) with videos related to
Sort By:
Pageof 68
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2008
BRCA germline mutations in Jewish patients with pancreatic adenocarcinomaCristina R Ferrone, Douglas A Levine, Laura H Tang, et al.Familial Cancer|November 2, 2004
A636P testing in Ashkenazi JewsJose G Guillem, Harvey G Moore, Crystal Palmer, et al.Cancer|June 28, 2012
Incorporating information regarding preimplantation genetic diagnosis into discussions concerning testing and risk management for BRCA1/2 mutations: a qualitative study of patient preferencesKaren Hurley, Lisa R Rubin, Allison Werner-Lin, et al.BMC Genetics|September 24, 2004
No major association between TGFBR1*6A and prostate cancerVirginia Kaklamani, Lisa Baddi, Diana Rosman, et al.Psycho-Oncology|July 19, 2008
Support needs and acceptability of psychological and peer consultation: attitudes of 108 women who had undergone or were considering prophylactic mastectomyAndrea F Patenaude, Sara Orozco, Xiaochun Li, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2008
American Society of Clinical Oncology policy statement: the role of the oncologist in cancer prevention and risk assessmentRobin T Zon, Elizabeth Goss, Victor G Vogel, et al.NPJ Breast Cancer|July 20, 2017
Prevalence and predictors of androgen receptor and programmed death-ligand 1 in <i>BRCA1</i>-associated and sporadic triple-negative breast cancerNadine Tung, Judy E Garber, Michele R Hacker, et al.Urologic Oncology|January 3, 2016
Outcome of genetic evaluation of patients with kidney cancer referred for suspected hereditary cancer syndromesKelly L Stratton, Shaheen Alanee, Emily A Glogowski, et al.Gynecologic Oncology|November 24, 2020
Embedding a genetic counselor into oncology clinics improves testing rates and timeliness for women with ovarian cancerHuma Q Rana, Lindsay Kipnis, Kristin Hehir, et al.Methodsx|July 1, 2022
An optimized protocol for evaluating pathogenicity of <i>VHL</i> germline variants in patients suspected with von Hippel-Lindau syndrome: Using somatic genome to inform the role of germline variantsDiane R Koeller, Danielle K Manning, Alison Schwartz, et al.Pageof 68